Histone modifying enzymes and cancer: Going beyond histones
Open Access
- 19 September 2005
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 96 (6) , 1137-1148
- https://doi.org/10.1002/jcb.20615
Abstract
Mutations in the molecular pathways that regulate cell proliferation, differentiation, and cell death all contribute to cancer formation. Enzymes that covalently modify histones affect these pathways by controlling the dynamic remodeling of chromatin structure. This article reviews several connections between histone modifying enzymes and cancer that are likely mediated via both histone and non‐histone substrates. We propose that multiple protein modifications, including phosphorylation, methylation, and acetylation, cross regulate one another to coordinate intermolecular signaling, and that miscues in this regulation can lead to oncogenesis. J. Cell. Biochem.Keywords
This publication has 54 references indexed in Scilit:
- Chromatin modifiers and carcinogenesisTrends in Cell Biology, 2004
- Around the World of DNA Damage INO80 DaysCell, 2004
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosisGenes & Development, 2003
- Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathwayNature Cell Biology, 2003
- Transitions in Distinct Histone H3 Methylation Patterns at the Heterochromatin Domain BoundariesScience, 2001
- Translating the Histone CodeScience, 2001
- The language of covalent histone modificationsNature, 2000